Article Versions Notes

Opazo-Ríos L, Plaza A, Sánchez Matus Y, Bernal S, Lopez-Sanz L, Jimenez-Castilla L, Carpio D, Droguett A, Mezzano S, Egido J, et al. Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy. International Journal of Molecular Sciences. 2020; 21(12):4225. https://doi.org/10.3390/ijms21124225

Opazo-Ríos, Lucas, Anita Plaza, Yenniffer Sánchez Matus, Susana Bernal, Laura Lopez-Sanz, Luna Jimenez-Castilla, Daniel Carpio, Alejandra Droguett, Sergio Mezzano, Jesús Egido, and et al. 2020. "Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy" International Journal of Molecular Sciences 21, no. 12: 4225. https://doi.org/10.3390/ijms21124225

Opazo-Ríos, L., Plaza, A., Sánchez Matus, Y., Bernal, S., Lopez-Sanz, L., Jimenez-Castilla, L., Carpio, D., Droguett, A., Mezzano, S., Egido, J., & Gomez-Guerrero, C. (2020). Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy. International Journal of Molecular Sciences, 21(12), 4225. https://doi.org/10.3390/ijms21124225